Trials / Completed
CompletedNCT00434187
Study to Evaluate Multiple Doses of ERB-041 in Healthy, Female Japanese Subjects
An Ascending Multiple Dose Study of the Safety, Tolerability and Pharmacokinetics of ERB-041 Administered Orally to Healthy, Female Japanese Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (planned)
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer · Industry
- Sex
- Female
- Age
- 20 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The primary objective is evaluate the safety, tolerability, and pharmacokinetics of multiple doses of ERB-041, an investigational drug, in healthy, female Japanese subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ERB-041 |
Timeline
- Start date
- 2006-08-01
- Completion
- 2006-10-01
- First posted
- 2007-02-13
- Last updated
- 2009-07-10
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT00434187. Inclusion in this directory is not an endorsement.